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The longevity of an organism depends on the health of its cells. Throughout life cells are
exposed to numerous intrinsic and extrinsic stresses, such as free radicals, generated
through mitochondrial electron transport, and ultraviolet irradiation. The cell has evolved
numerous mechanisms to scavenge free radicals and repair damage induced by these
insults. One mechanism employed by the yeast Saccharomyces cerevisiae to combat
stress utilizes theAnaphase Promoting Complex (APC), an essentialmulti-subunit ubiquitin-
protein ligase structurally and functionally conserved from yeast to humans that controls
progression through mitosis and G1. We have observed that yeast cells expressing com-
promised APC subunits are sensitive to multiple stresses and have shorter replicative and
chronological lifespans. In a pathway that runs parallel to that regulated by the APC, mem-
bers of the Forkhead box (Fox) transcription factor family also regulate stress responses.
The yeast Fox orthologs Fkh1 and Fkh2 appear to drive the transcription of stress response
factors and slow early G1 progression, while the APC seems to regulate chromatin struc-
ture, chromosome segregation, and resetting of the transcriptome in early G1. In contrast,
under non-stress conditions, the Fkhs play a complex role in cell-cycle progression, partially
through activation of the APC. Direct and indirect interactions between the APC and the
yeast Fkhs appear to be pivotal for lifespan determination. Here we explore the potential
for these interactions to be evolutionarily conserved as a mechanism to balance cell-cycle
regulation with stress responses.
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INTRODUCTION
Throughout history humanity has sought to understand the rea-
sons for aging and dying. Relatively recently, genetic and bio-
chemical studies have offered some insight into these complex
processes. The health of an organism is directly related to the
health of its cellular constituents, with genomic instability being
a dominant force that leads to either senescence of stem cells
or uncontrolled growth and tumor formation. Advances in our
understanding of these processes have been made through the
identiﬁcation of gene products that can increase or decrease
cellular health span, inﬂuencing the incidence of tissue degen-
eration and age-related diseases, such as Alzheimer’s, diabetes,
and cancer (reviewed in Kloet and Burgering, 2011; Stünkel and
Campbell, 2011; Ziv and Hu, 2011; Jia et al., 2012; Salminen and
Kaarniranta, 2012). Genetic screens in the nematode Caenorhab-
ditis elegans identiﬁed members of the insulin-signaling pathway
as regulators of the aging process. Speciﬁcally, decreased activ-
ity of the PI3K/AKT pathway, a prominent pathway overactive
in many cancer cells, increases longevity in a variety of model
organisms (Kloet and Burgering, 2011; Speakman and Mitchell,
2011).
Regulation of growth in conjunction with stress resistance and
genomic stability was found to rely on the worm Daf-16, a stress
response transcription factor featuring the forkhead box (Fox)
DNA-binding domain (Kenyon et al., 1993; Lin et al., 2001; Lib-
ina et al., 2003; Murphy et al., 2003). Fox-containing proteins
have been identiﬁed from yeast to worms and insects to humans
(Baldauf, 1999; Mazet et al., 2003). Fox family members regulate
diverse biological processes, such asmetabolism, embryonic devel-
opment, differentiation, cell migration, invasion, cell-cycle pro-
gression, apoptosis, autophagy, immunity, DNA-damage repair,
and toxin scavenging (Tuteja and Kaestner, 2007). A large num-
ber of Fox genes have been identiﬁed in higher eukaryotic systems
(Kaufmann and Knöchel, 1996; Murakami et al., 2010), which
makes it very difﬁcult to gain insight into any one Fox protein
or subfamily. The brewing yeast Saccharomyces cerevisiae contains
only four Fox proteins (Fkh1, Fkh2, Fhl1, and Hcm1; Murakami
et al., 2010), presenting an opportunity to learn in greater depth
how individual Fox proteins are regulated and what they control.
It has become apparent that unraveling the regulation, targets,
and evolution of the Fox family of transcription factors is cru-
cial for understanding cancer biology and aging, as this group
contains suspected oncogenes, as well as bona ﬁde tumor sup-
pressors and longevity determining factors. Emerging evidence
highlights the importance of these factors in cell-cycle regulation
and stress responses, through the regulation of the evolutionary
conserved Cyclins, Cyclin Dependent Kinase inhibitors (CDKIs),
and theAnaphase PromotingComplex (APC), a ubiquitin-protein
ligase. Here we explore the evolutionary conservation of these
mechanisms from yeast to humans.
THE EVOLUTIONARILY CONSERVED FOX FACTORS
Fox transcription factors have been identiﬁed in a wide range of
species from yeast to humans based on the common 110-amino-
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acid winged-helix DNA-binding domain, known as the forkhead
box (Kaufmann et al., 1995; Kaufmann and Knöchel, 1996). Due
to the highly conserved nature of the Fox DNA-binding domain,
all Fox proteins bind to the consensus core nucleotide sequence
A/CAAC/TA (Lalmansingh et al., 2012). Although Fox genes have
been found in animals, as well as yeast and other fungi, plants do
not encode these transcription factors. This suggests the proto-Fox
gene originated in the animal/fungal ancestor after the evolu-
tionary split of autotrophs and heterotrophs (Baldauf, 1999).
Phylogenetic and comparative analyses have identiﬁed over 100
Fox genes in humans that can be subgrouped into 19 subclasses (A
to S) with further subdivision based on the relationship between
vertebrate and invertebrate genes (Kaufmann and Knöchel, 1996;
Hannenhalli and Kaestner, 2009; Murakami et al., 2010). Analyses
of fungal Fox genes found they were equally related to all animal
Fox genes, suggesting only one proto-Fox gene was present at the
divergence of animals and fungus (Baldauf, 1999).
A fascinating aspect of Fox gene function is their involvement
in many developmental defects and cancer (Lehmann et al., 2003;
Myatt and Lam, 2007). This review will focus on two closely
related subclasses: the aging and tumor suppressor FoxO and the
oncogenic FoxM.
The FoxO subclass is highly conserved throughout animals and
is primarily responsible for regulation of G2-M and G1-S cell-
cycle checkpoints, as well as for the expression of stress response,
DNA repair, and apoptotic genes (Brunet et al., 1999; Medema
et al., 2000; Dijkers et al., 2002; Kops et al., 2002; Nemoto and
Finkel, 2002; Tran et al., 2002). The FoxO subclass is of spe-
cial interest as its members seem intrinsic to tumor suppression
and lifespan extension. Intense investigation of post-translational
regulation of the FoxOs is underway, wherein phosphorylation,
acetylation, and ubiquitination (both poly and mono) are known
to inﬂuence FoxO nuclear shuttling, DNA-binding ability, tran-
scriptional activity, and protein stability (Calnan and Brunet,
2008; Boccitto and Kalb, 2011; Daitoku et al., 2011; Huang and
Tindall, 2011; Tzivion et al., 2011; Zhao et al., 2011). Under non-
stress conditions, phosphorylation of FoxOs by growth factor
(insulin/insulin-like growth factor, TOR2C and Mitogen acti-
vated kinase) pathways results in cytosolic (rather than nuclear)
localization and proteasome-dependent degradation via ubiqui-
tination by the Skp/Cullin/F-box ubiquitin-protein ligase (E3)
complex SCFSkp2. Conversely, stress-induced phosphorylation sig-
nals (oxidative stress activated c-Jun N-terminal kinase and MST1,
as well as starvation response AMPK) result in nuclear local-
ization and the transcription of speciﬁc factors. Furthermore,
FoxO acetylation leads to dissociation from DNA, while simulta-
neously stabilizing FoxO proteins by blocking ubiquitination and
subsequent degradation.
FoxM1, the singlemember of the FoxMsubfamily, is foundonly
in proliferating cells, and is also involved in cell-cycle regulation,
aging, and cancer (Korver et al., 1997; Mazet et al., 2003; Laoukili
et al., 2007;Tang et al., 2008; Pandit et al., 2009; Petrovic et al., 2010;
Wang et al., 2010). Cells deﬁcient in FoxM1 show delays in G2/M
and G1/S progression, as well as defects in chromosome segrega-
tion and cytokinesis (Laoukili et al., 2005; Wang et al., 2005, 2008;
Ustiyan et al., 2009). Increased FoxM1 protein has been found in
numerous types of cancer and may be involved in early stages of
tumorigenesis (Wilson et al., 2011). Like FoxO proteins, FoxM1
is also involved in DNA repair, implicating a need for FoxM1 in
genomic stability and survival. Phylogenetic analyses suggest that
the FoxM subclass is an offshoot of the FoxO family that split early
in vertebrate evolution as no known structural ortholog has been
found in modern chordate or invertebrate species (Mazet et al.,
2003).
A possible direct connection between FoxO3a and FoxM1 was
suggested by microarray analyses of FoxO3a overexpressing cells,
which identiﬁed FoxM1 as a gene differentially repressed when
Fox3a levels were increased (Delpuech et al., 2007). Of the 151
differentially expressed genes (>2-fold up or down), 59 (39.1%)
were downregulated. A large percentage of the cell-cycle regu-
lated genes were downregulated, consistent with a role for FoxO3a
in cell-cycle inhibition. FoxM1 was previously identiﬁed as a Myc
target gene containing E-boxes (CACTGT) within the FoxM1 pro-
moter at −1244 and −1091 (Figure 1; Fernandez et al., 2003).
Myc forms a heterodimer with Max, which binds the E-box to
activate gene expression. Contrary to this, Max can also dimerize
with Mxi1 to bind E-boxes, resulting in transcriptional repression
(Delpuech et al., 2007). Increased FoxO3a expression upregu-
lated members of the Mad/Mxi family, which was predicted to
antagonize Myc function. It was concluded that downregulation
of FoxM1 following FoxO3a induction may be an indirect effect
of Myc inhibition via up-regulation of the Myc antagonists Mxi1
and Mad. It was also observed that increased FoxO3a expression
decreased Myc protein levels, providing an additional mechanism
for FoxM1 repression. However, it should be noted that FoxM1
contains a TAAACA Fox binding site at position −88 within the
FoxM1 promoter (Figure 1), indicating that FoxO3a may indeed
bind and repress the FoxM1 promoter, perhaps ﬁrst requiring the
displacement of Myc.
The reciprocal interaction of FoxO3a and FoxM1 is critical to
stave off cancer (Wilson et al., 2011). Previous work indicated
that repression of FoxM1, via FoxO3a, was necessary to suppress
the growth of breast cancer cells treated with the EGRF inhibitor
Geﬁtinib (McGovern et al., 2009). It was observed that Geﬁtinib
induced the expression of FoxO3a in association with the repres-
sion of FoxM1. Silencing of FoxO3a increased FoxM1 expression
in response to Geﬁtinib, which was associated with increased cell
proliferation and reduced cell death. Similarly, increased FoxM1
expression reduced Geﬁtinib induced cell-cycle arrest.
FoxO3a and FoxM1 also appear to oppose one another in ERα-
positive breast cancer cells. FoxO3a was identiﬁed as a binding
partner for ERα and ERβ, which was important for the sup-
pression of estrogen-dependent breast cancer (Zou et al., 2008).
This interaction resulted in the repression of ERα-regulated gene
expression (Figure 2). Conversely, FoxM1 was shown to drive
the expression of ERα via “promoter A” of the two-set ERα pro-
moter (Figure 2), and that silencing of FoxM1 completely blocked
ERα expression (Madureira et al., 2006). It was also observed that
FoxO3a could promoteweak expressionof ERα throughERα“pro-
moter B.” However, both FoxM1 and FoxO3a could bind to both
ERα promoter sets. Lastly, although FoxM1 and FoxO3a could be
co-immunoprecipitated the relevance of this observation was not
pursued. The compiled evidence suggests that FoxM1 and FoxO3a
may form a complex that cooperatively regulates ERα expression.
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FIGURE 1 | FoxM1 expression is repressed by FoxO3a. FoxO3a may
repress FoxM1 expression in one of three ways, which may not be
mutually exclusive. First, FoxO3a may bind to a Fox consensus site at
position −88 of the FoxM1 promoter. This could lead to FoxM1
repression. Second, expression of the Myc antagonists Mad and Mxi1
are driven by FoxO3a. Mad and Mxi1 compete with Myc to dimerize
with Max. The Max/Myc dimer binds to E-boxes (CACTGT) located
within the FoxM1 promoter to drive FoxM1 expression, while Mad/Max
and Mxi1/Max dimers bind the same E-boxes, but repress expression.
Thus, increased expression of Mxi1 and Mad by FoxO3a could inhibit
FoxM1 expression by blocking Myc/Max dimerization. Third, Myc
protein levels decrease when FoxO3a expression is increased, perhaps
through a post-translational mechanism, providing another method to
potentially repress FoxM1 expression following FoxO3a activation. This
ﬁgure is based on work from Delpuech et al. (2007) and Fernandez
et al. (2003).
However, these interactions could also be interpreted to imply that
FoxO3a can bind FoxM1 at promoters to inhibit FoxM1 activ-
ity. Much more work is required to elucidate the mechanisms
regulating ERα expression and breast cancer progression.
YEAST FOX PROTEINS
The budding yeast S. cerevisiae contains four Fox genes: FKH1,
FKH2, HCM1, and FHL1. FHL1 regulates ribosome biogenesis
(Rudra et al., 2005), and HCM1 regulates progression through
G2, preparing the cell for mitosis (Pramila et al., 2006). Although
both may play a role in lifespan determination, their individual
deletion did not inﬂuence yeast replicative lifespan (RLS; a mea-
sure of how many daughter cells a single mother can produce;
Kennedy et al., 1994;Wei et al., 2008). Here we focus on FKH1 and
FKH2 as they show conserved function with human FoxM/FoxO
genes (Murakami et al., 2010; Postnikoff et al., 2012). Genetic
redundancy is suggested for these two factors as the combined
deletion of both FKH1 and FKH2 is necessary to alter growth,
stress response, longevity, cell morphology, and gene transcription
phenotypes (Hollenhorst et al., 2000;Zhu et al., 2000; Shapira et al.,
2004; Sherriff et al., 2007; Voth et al., 2007; Postnikoff et al., 2012).
Evolutionary conservation for FKH1 and FKH2 with higher Fox
genes is suggested by their similar involvement in ROS induced
cell-cycle arrest and resistance to oxidative stress during station-
ary phase (Shapira et al., 2004; Postnikoff et al., 2012), as well as
in cell-cycle regulation through both G1 and G2/M gene clusters
(Zhu et al., 2000). Finally, we have recently found that deletion of
both FKH1 and FKH2 reduces lifespan in a manner that inhibits
lifespan extension due to caloric restriction, while over-expression
of one or both genes extends lifespan (Postnikoff et al., 2012),
hallmarks of human FoxO genes.
Fkh1 and Fkh2 are capable of binding the Forkhead box con-
sensus site (TAAACA) ﬁrst identiﬁed for Xenopus XFD1, 2, and
3 (Kaufmann et al., 1995). Under normal laboratory conditions
Fkh2primarily occupies knownbinding sites of theClb2 gene clus-
ter. Fkh2 forms a complexwith theMADS-box transcription factor
Mcm1, while Fkh1 does not (Hollenhorst et al., 2001). Cell-cycle
speciﬁc activation of this complex is initiated by the expression
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FIGURE 2 | A complex interaction between FoxM1 and FoxO3a
controls ERα expression.The ERα promoter contains two clusters of Fox
binding sites, one immediately upstream of the ERα start site, “Promoter
A” and a second site at approximately position −3000, “Promoter B.” ChIP
studies showed that FoxM1 and FoxO3a could bind both promoters.
Based on RNAi experiments, FoxM1 and FoxO3a were both capable of
driving ERα expression, although through Promoters A and B, respectively,
with FoxM1 playing a dominant role. A second level of complexity involves
a protein/protein interaction between FoxO3a and ERα that blocks ERα
from promoting the transcription of ERα responsive genes. A potential
FoxO3a/FoxM1 physical interaction provides a third possible layer of
complexity. The relevance of the FoxO3a/FoxM1 interaction remains
unknown. This ﬁgure is based on work by Zou et al. (2008) and Madureira
et al. (2006).
and binding of the co-activator Ndd1 to Fkh2, which switches
the function of Fkh2 from repressor to activator (Loy et al., 1999;
Koranda et al., 2000). Fkh1 may function as a co-regulator of this
process, or may function as a primary regulator under alternate
growth conditions. In FKH2 deletion strains, cell-cycle speciﬁc
expression of Fkh2 targets is not disrupted, as it is in fkh1Δ fkh2Δ
double mutant strains (Zhu et al., 2000; Hollenhorst et al., 2001),
suggesting Fkh1 can function at the same loci without Fkh2/Ndd1
occupancy (Reynolds et al., 2003). However the mechanism by
which Fkh1 regulates these genes in a periodic cell-cycle depen-
dent manner, in the absence of Fkh2 and Ndd1, requires further
investigation.
COMMON BIOLOGY OF THE FKHs AND THE FOXs
Mitotic progression genes are common targets of both yeast and
human Fox proteins. As described earlier, the yeast Fkh1 and Fkh2
regulate clusters of genes required for cell-cycle progression, such
as the CLN2 and CLB2 gene clusters (Zhu et al., 2000), which
include targets (Iqg1, Cdc20, the B type cyclins Clb1, Clb2, Clb5,
and the yeast the polo-like kinase Cdc5) and regulators (Clb2,
Cdc20, and Cdc5) of the APC (Ko et al., 2007; Sari et al., 2007;
Qiao et al., 2010). The APC is a highly conserved ubiquitin-
protein ligase (E3) that primarily controls progression through
mitosis and G1. The observation that the Fkh proteins control
transcription of many genes required for APC function suggests
that the APC may be a critical downstream target of the Fkhs
(discussed in more detail below). The Fkh proteins also control
the transcription of the Histone gene cluster (Zhu et al., 2000).
Interestingly, the yeast APC is required for histone protein expres-
sion and post-translational modiﬁcation, which may be a shared
feature with the Fkh proteins, as deletion of FKH1 and FKH2
in a mutant apc5CA background further impairs histone protein
levels (Turner et al., 2010; Postnikoff et al., 2012). In mammals,
FoxM1 primarily regulates G2/M genes, such as B type cyclins,
the polo-like kinase (PLK-1), Aurora B, Skp2, INCENP, Nek2, and
the centromere speciﬁc proteins CENP-A, CENP-B, and CENP-F
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(Laoukili et al., 2005; Wang et al., 2005). Like in yeast, many of
the FoxM1 controlled genes are either required for APC func-
tion (PLK-1, B type cyclins), or are targeted for degradation by the
APC (Aurora B, Skp2,Nek2, PLK-1, and B type cyclins; Pﬂeger and
Kirschner, 2000; Qiao et al., 2010). An additional level of striking
conservation between mammalian and yeast cells is the positive
feedback loop that initiates an irreversible commitment to mitosis,
wherein Cdk-cyclin B complexes and polo-like kinases phospho-
rylate FoxM1 and the Fkhs to increase their transcriptional activity
(Murakami et al., 2010).
Many of the FoxM1 targets are required for genomic stability
(O’Brien et al., 2007; van derWaal et al., 2012). For example, silenc-
ing of CENP-F (activated by FoxM1) resulted in the loss of the
mitotic checkpoint proteins Mad1 and BubR1, which are required
to block APC activity until appropriate (Laoukili et al., 2005). The
subsequent inappropriate activation of the APC in the presence of
DNAdamage could result in potentialmitotic catastrophe (D’Arcy
et al., 2010; Lara-Gonzalez et al., 2011). Likewise, the Chromoso-
mal Passenger Complex, composed of Aurora B kinase, INCENP,
Survivin, and Borealin, regulates the mitotic checkpoint to ensure
accurate segregation of mitotic chromosomes (van der Waal et al.,
2012). Thus, FoxM1 expression at least in part increases mitotic
checkpoint control and APC function, ensuring proper transit
through mitosis. Considering that improved mitotic checkpoints
should result in increased genomic stability, not in cancer devel-
opment, this apparent paradox may reﬂect a mechanism whereby
increased FoxM1 expression in cancer cells allows the defective cell
to bypass cellular mechanisms aimed at destroying it. FoxM1 itself
is a target of the APCCdh1 G1 speciﬁc complex (Laoukili et al.,
2008; Park et al., 2008). This is an interesting ﬁnding since FoxM1
joins the growing list of APC activators that are later targeted by
the APC for degradation to complete a negative feedback loop. It
is thought that in order to shut down the expression of mitosis-
speciﬁc genes, FoxM1 must be degraded as cells exit mitosis. Our
unpublished data suggests that the targeting of Fox proteins by
the APC is indeed a conserved process, as the yeast Fkh1 is tar-
geted by the APC during G1 for degradation (Malo, Postnikoff,
and Harkness, unpublished).
Stability of the FoxO and FoxM proteins is controlled antag-
onistically by the SCF and APC ubiquitin-protein ligase/E3 com-
plexes, respectively. The APC targets FoxM1 for degradation, and
indirectly stabilizes FoxO during G1 (Laoukili et al., 2008; Park
et al., 2008). The SCFSkp2 complex targets phosphorylated FoxO
proteins for degradation (Huang et al., 2005; Huang and Tindall,
2011). The APC potentially controls this process through targeted
degradation of the F-box protein Skp2 (van Leuken et al., 2008);
degradation of Skp2 by the APCCdh1 blocks SCFSkp2 function,
thereby delaying FoxO degradation and allowing increased FoxO
tumor suppressor activity. There appears to be a battle over the
control of Skp2 stability in mammalian cells. AKT phosphorylates
FoxO proteins, leading to their SCFSkp2-dependent ubiquitination
and degradation. AKT also phosphorylates Skp2 (Gao et al., 2009;
Lin et al., 2009). AKT phosphorylation of Skp2 is believed to sig-
nal cytosolic localization of Skp2, thereby protecting Skp2 from
APC-dependent ubiquitination and degradation. However, this
mechanism may be cell type dependent, as another study was not
able to reproduce these results (Bashir et al., 2010). Nonetheless,
the APC andAKT may be competing for Skp2’s attention,with the
winner perhaps deciding between cell health and death.
Opposing FoxO3a and FoxM1 function exists at the tran-
scriptional target level as well. As already mentioned, FoxM1 is
repressed by FoxO3a (Figure 1). However, FoxO3a also represses
the expression of many cell-cycle speciﬁc genes, consistent with its
role in blocking cell-cycle progression (Delpuech et al., 2007). The
G2/M genes activated by FoxM1, such as UBE2C, NEK2, CENP-
F, and Aurora, were repressed by FoxO3a (Laoukili et al., 2005;
Delpuech et al., 2007). FoxO3a was more likely to activate the
expression of genes required for apoptosis/stress response, tran-
scription, and signaling (Delpuech et al., 2007). This pattern was
also observed when asynchronous fkh1Δ fkh2Δ cells were used
for microarray analyses, with downregulation of genes involved
in cell stress response (RNR1, ALK1, IRC8, PHO5/11/12, DSE1/2,
CRG1; Zhu et al., 2000). Importantly, these genes all contain the
Fox TAAACA binding site within 1 kb of the start site. Thus, the
yeast Fkh1 and Fkh2 stress response transcription factors appear
to possess activities associated with both FoxM1 and FoxO3a.
Another conserved role for these proteins is in the regulation
of cell-cycle arrest and check point genes through two different
mechanisms: the induction of cell-cycle arresting agents, such
as CDKIs, and the repression of cell-cycle regulators, such as
cyclins and polo-like kinases. The FoxOs regulate G1/G0 cell-cycle
arrest by induction of the CDKIs p27Kip1, p21Cip1, p15Ink4b,
p19INK4d, and p19Arf, which inhibit the formation of S-phase
entry cyclin-CDK complexes (Medema et al., 2000; Seoane et al.,
2004; Gomis et al., 2006; Bouchard et al., 2007; Miyamoto et al.,
2007; Katayama et al., 2008). In addition, the FoxOs are involved
in increasing the level of expression of the quiescent cyclin G2
while repressing that of cell-cycle entry cyclin D family members
(Ramaswamy et al., 2002; Schmidt et al., 2002; Martínez-Gac et al.,
2004). Furthermore, the FoxOs prevent the transcriptional activa-
tion of cell-cycle entry proteins through the up-regulation of the
retinoblastoma protein family member p130 (Kops et al., 2002).
Similarly, the FoxOs may be involved in check point arrest through
the regulation of GADD45α, a component of the G2 checkpoint
and DNA-damage repair systems (Tran et al., 2002; Laoukili et al.,
2005).
The yeast Fkhs appear to function in a similar manner to the
FoxOs through complimentary mechanisms. As mentioned ear-
lier, Fkh2 in vivo is dominant over Fkh1 at promoter-binding sites
where it acts as a transcriptional inhibitor until it binds the co-
activator Ndd1 (Loy et al., 1999; Koranda et al., 2000; Hollenhorst
et al., 2001). Thus, Fkh2 acts to block the expression of G2/M
progression genes until the appropriate growth signals regulating
the binding of Ndd1 to Fkh2 are present. At this point there is a
switch to mitotic progression via the up-regulation of Clb2 and
Cdc5, which further activates the Fkh2/Ndd1 complex (Reynolds
et al., 2003). The expression of other genes, such as the rest of the
Clb2 gene cluster is similarly regulated: this includes the APC sub-
units/activators and the G1 transcription factors Swi5 and Ace2,
as well as the Histone gene cluster (Zhu et al., 2000). Swi5 and
Ace2 are responsible for the expression of M/G1 progression genes
as well as the yeast CDKI Sic1. In late mitosis the proteasomal
degradation of Ndd1 switches Fkh2 to a transcriptional repres-
sor of the Clb2 gene cluster. Interestingly, the Fkhs also bind to
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and repress many Swi5/Ace2 targeted promoters, preventing early
G1 progression. As it appears Fkh1 is functionally redundant with
Fkh2 (Hollenhorst et al., 2000; Zhu et al., 2000; Shapira et al., 2004;
Sherriff et al., 2007; Voth et al., 2007; Postnikoff et al., 2012), it can
be conﬁdently postulated that the Fkhs follow the same pattern of
cell-cycle regulation as the human Fox proteins, switching from
cell-cycle repression in G2, to activation in M, followed by early
G1 repression.
THE ROLE OF FOX PROTEINS IN LIFESPAN DETERMINATION
The FoxO family of proteins have been reproducibly found to
extend lifespan when expression is increased in many model sys-
tems studied, including ﬂies, worms, and yeast (Libina et al., 2003;
Giannakou et al., 2007;Postnikoff et al., 2012). TheC. elegans FoxO
ortholog DAF-16 was found to serve as a direct downstream tar-
get of the worm insulin-signaling pathway (Kenyon et al., 1993).
Worm mutants encoding defective daf-2 insulin receptor genes
exhibited a twofold lifespan extension, which was abolished when
daf-16 was mutated. Since the ﬁrst studies of DAF-16 in worms,
inactivation of the insulin-signaling pathway fromﬂies andworms
to mice has resulted in extended lifespan (Kenyon et al., 1993;
Carter et al., 2002; Blüher et al., 2003; Holzenberger et al., 2003;
Rincon et al., 2004). For the most part, lifespan extension through
reduced insulin-signaling depends on the evolutionarily conserved
FoxO factors.Mutation to the FoxO stress response factors reduces
lifespan and stress response in many model systems (Lin et al.,
2001; Greer and Brunet, 2008; Moskalev et al., 2011; Yamamoto
and Tatar, 2011; Postnikoff et al., 2012). While independent muta-
tion to either yeast FKH1 or FKH2 has no effect on replicative
or chronological lifespan (CLS; Wei et al., 2008; Postnikoff et al.,
2012), a combined deletion of both FKH1 and FKH2 in the same
cell dramatically impairedCLS and these cells could not respond to
severe caloric restriction induced by maintenance in water (Post-
nikoff et al., 2012). As opposed to RLS, CLS measures how long
stationary phase cells can remain metabolically active (Fabrizio
et al., 2001; Longo and Fabrizio, 2012). The requirement for Fkh1
or Fkh2 for maintenance of stationary phase metabolic activity
indicates that the yeast Fkh1 and Fkh2 proteins are fully active in
non-dividing cells. This was supported by experiments demon-
strating that fkh1Δ fkh2Δ cells are far more sensitive to oxidative
stress when in stationary phase than when rapidly dividing (Post-
nikoff et al., 2012). Since yeast cells do not naturally respond
to insulin, this indicates that yeast respond to nutrients directly
through evolutionarily conserved insulin-like signaling mecha-
nisms. In this respect, insulin may act as a “middle-man” in
multi-cellular organisms, indicating to cells that express an insulin
receptor that nutrients are available.
A series of studies focused on long-lived human popula-
tions have convincingly shown that long-lived individuals express
altered insulin-signaling. A study of female human centenarians
revealed that these individuals carry a heterozygous mutation in
the IGF1 receptor that was over-representative compared to con-
trols (Suh et al., 2008). Transformed lymphocytes generated from
these individuals revealed reduced insulin-signaling. Other long-
lived human cohorts were found to carry an altered FoxO3a allele
that was not generally found in the population (Willcox et al.,
2008; Chung et al., 2010; Ziv and Hu, 2011). Taken together, the
ﬁndings in model systems ranging from yeast to mice clearly show
that increased lifespan as a result of diminished insulin-signaling
is a trait likely conserved in humans.
FoxM1 also appears to play a critical role in cell survival with
respect to cancer cells. FoxM1 is highly expressed in many cancer
cells and most weakly expressed in prematurely aging ﬁbroblasts,
such as those isolated from individuals suffering from Progeria,
a rapid aging phenotype (Laoukili et al., 2007; Zeng et al., 2009;
Anders et al., 2011). From these observations, it is clear that FoxM1
expression is associated with the proliferative capacity of the cell,
consistentwith its role in primarily driving the expression of G2/M
speciﬁc genes (Laoukili et al., 2005), with associated phenotypic
expression of mitotic defects and chromosome aberrations when
defective (Wonsey and Follettie, 2005). As such, FoxM1 appears to
be tightly linked with inducing the expression of genes required
for G2 and mitotic progression, very similar to the yeast Fkh1
and Fkh2 Fox proteins. FoxM1 seems to counter senescence, but
primarily to maintain the life of cancer cells.
DOWNSTREAM FOX TARGETS REQUIRED FOR INCREASED
LIFESPAN
A major quest over the past decade has been to identify down-
stream targets of the FoxO proteins speciﬁcally required for lifes-
pan extension in model systems. The primary model used for
these screens to identify FoxO lifespan targets has been the nema-
tode C. elegans, largely due to the emergence of RNAi libraries
(Murphy et al., 2003; Murphy, 2006; Oh et al., 2006; Szewczyk
et al., 2006; Pinkston-Gosse and Kenyon, 2007; Shmookler et al.,
2009; Schuster et al., 2010). An early study performed microar-
ray on a series of long- and short-lived worm mutants over a
lengthy time course spanning their overall development (Mur-
phy et al., 2003). The 60 experiments were combined and mined
for differentially expressed genes. Genes were found that grouped
into distinct clusters representing signaling, stress response, and
antimicrobial responses. Many of these genes were then silenced
by RNAi in order to determine lifespan. Although many of the
silenced genes conferred lifespans that altered from wild type con-
trols, none of the lifespan differences approached those observed
with daf-2 mutants, leading to the conclusion that multiple effec-
tor genes involved in longevity determination are regulated by the
insulin-signaling pathway.Using chromatin immunoprecipitation
(ChIP) 103 speciﬁc promoters were identiﬁed as bound by DAF-
16 (Oh et al., 2006). Again using RNAi, few of these genes were
seen to be involved in lifespan in isolation, although several were
controlled by insulin-signaling. This study suggested that either
(i) multiple proteins are involved in DAF-16 functions, or (ii)
DAF-16 may have non-productive promoter interactions. A rigor-
ous examination of microarray data from long-lived worms, ﬂies,
and mice that were impaired in insulin-signaling showed a strik-
ing lack of convergence between the differentially expressed genes
(McElwee et al., 2007). Nonetheless, several functional categories
were found to be conserved, such as protein biosynthesis, sugar
catabolism, energy generation, and cellular detoxiﬁcation. A novel
approach to identifying DAF-16 targets involved fusing DAF-16
with a bacterial DNA adenine methyltransferase (DAM), which
methylates adenine residues within the sequence GATC anywhere
within 2 kb of its binding site (Schuster et al., 2010).An original list
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of 907 promoters was whittled down to 65 DAF-16 targets. This
list was largely enriched in genes involved in signaling, and not
in genes required for somatic maintenance processes, suggesting
that DAF-16 is more likely activating signaling processes that lead
to cellular maintenance and protection, rather than the individ-
ual genes themselves. Although dramatic gains have been made in
identifying DAF-16 targets required for longevity determination,
surprisingly little ground has beenmade toward deﬁning networks
leading from DAF-16 that result in deﬁnitive increased lifespan.
THE ANAPHASE PROMOTING COMPLEX, AN EMERGING FOX
SPECIFIC TARGET BRIDGING THE LONGEVITY GAP
Emerging evidence suggests that the APC may be an important
downstream target necessary for many Fox/Fkh functions (Laouk-
ili et al., 2008; Park et al., 2008; Postnikoff et al., 2012). TheAPC is a
highly conserved multi-subunit ubiquitin-protein ligase (E3) that
primarily targets proteins that inhibit chromosome segregation
and mitotic exit for ubiquitin- and proteasome-dependent degra-
dation (Qiao et al., 2010; McLean et al., 2011). Initiation of and
progression throughmitosis ismediated by theAPCCdc20 complex,
while exit from mitosis and maintenance of G1 is controlled by the
APCCdh1 complex, which targets components that drive mitosis,
such as Clb2, Cdc5, and Cdc20, for degradation. Cdc20 is acti-
vated by the polo-like kinase Cdc5, as well as by the Cdc28/Clb2
Cdk complex prior to chromosome segregation. APCCdc20 targets
spindle checkpoint proteins, such as the securin Pds1 in yeast, for
proteasomal degradation (Hilioti et al., 2001; Wang et al., 2001).
A speciﬁc example of such regulation involves the mouse spindle
checkpoint protein BubR1. The spindle checkpoint functions in
normal mitotic progression to inhibit APCCdc20 as a counter to
polo-like kinase activation, ensuring that chromosomes are prop-
erly attached to the mitotic spindle, thereby preventing changes in
chromosome numbers (D’Arcy et al., 2010; Lara-Gonzalez et al.,
2011). Mice deﬁcient in BubR1, either through mutation or as a
natural property of aging, show signs of early aging such as kypho-
sis, cataracts, cardiovascular disease,muscle wasting, and suscepti-
bility to carcinogens (Baker et al., 2004, 2005; Kim and Kao, 2005).
Proper regulation of APCCdc20 may increase chromosome segre-
gation ﬁdelity, reducing non-disjunction events, and potentially
increasing cellular healthspan. Other non-mitotic functions have
now been ascribed to the APC, including maintaining neuronal
development and genomic stability, as well as regulating chro-
matin metabolism and enhancing longevity in yeast and higher
eukaryotic organisms (Harkness et al., 2002, 2004, 2005; Baker
et al., 2004; Arnason et al., 2005; Turnell et al., 2005; Li et al., 2008;
Turner et al., 2010; Eguren et al., 2011; Islam et al., 2011; Puram
and Bonni, 2011; Postnikoff et al., 2012). As diverse as APC func-
tions seem to be, regulatory mechanisms controlling APC output
remain largely unknown.
Our recent work demonstrates that the APC may serve as
a downstream Fkh1/Fkh2 target that regulates Fox-dependent
longevity (Postnikoff et al., 2012). The APC and the Fkhs interact
genetically and functionally to ensure normal yeast lifespan, and
to respond to severe caloric restriction and stress in non-dividing
cells. As mentioned above, increased expression of FKH1 or FKH2
could increase both RLS and CLS in yeast (Postnikoff et al., 2012).
As expected from redundant factors, deletion of both FKH1 and
FKH2, rather than either one alone, was required to reduce yeast
CLS. However, disruption of both FKH1 and FKH2 in cells har-
boring a temperature sensitive allele of the gene encoding the APC
subunit APC5, exhibited a CLS that was the same as fkh1Δ fkh2Δ
cells, indicating that fkh1Δ fkh2Δ CLS is epistatic to apc5CA CLS
under normal culture conditions. This indicates that under non-
stress conditions Fkh1/2 acts directly upstream of the APC. We
believe that this is through the direct transcriptional regulation of
APC activators and APC substrates (Zhu et al., 2000).
The apc5CA mutant had a lifespan shorter than fkh1Δ fkh2Δ
cells (Postnikoff et al., 2012). Unlike an earlier C. elegans study
where RNAi of many DAF-16 targets (determined by microarray
analyses) did not generate lifespan alterations as impressive as daf-
2 or daf-16 mutants (Murphy et al., 2003), our data indicates that
the APC may indeed be capable of mediating the lifespan effects
of Fkh1/2 (Postnikoff et al., 2012). However, under stress condi-
tions, such as maintenance of stationary phase cells in water, or
exposure to either oxidative or heat stress, apc5CA fkh1Δ fkh2Δ
cells grew much slower, were far more sensitive to stress and had a
dramatically reduced CLS. While fkh1Δ fkh2Δ cells do not show
the normal increased CLS in water, the triple mutant exhibited
a dramatically shortened lifespan. This indicated that the Fkhs
and the APC work together in a redundant manner to respond
to stress and to ensure prolonged longevity. This is likely coordi-
nated through the transcriptional up-regulation of stress response
genes by Fkh1/2 in tandem with the chromatin assembly and his-
tone modiﬁcation functions of the APC (Harkness et al., 2002,
2005; Arnason et al., 2005; Turner et al., 2010; Islam et al., 2011).
Together, theAPC and the Fkhs drive response to stress and protect
the genome from environmental stressors.
CONCLUSION
A pattern is emerging where pro-mitotic processes act as cell-
cycle inhibitors to slow progression through early G1, allowing for
preparation of S phase by resetting the transcriptome, repairing
cellular damage, or remaining in a non-dividing state until condi-
tions are right for the next cell cycle. Stress and starvation may act
to prolong the function of this mechanism, allowing more time
for stress response and cell repair. However, growth factors and
energy sources inactivate these processes, favoring rapid growth
over maintenance of youth. In mammals this process is regu-
lated, at least in part, by the Fox class of transcription factors and
the APC. Speciﬁcally, FoxM1 and APCCdc20 function together to
maintain genomic stability by regulating separation of sister chro-
mosomes and chromatin structure, while the FoxOs and APCCdh1
regulate cellular repair and maintenance, as well as the removal of
built up pro-mitotic signals resetting the daughter cells. In yeast,
new evidence suggests that this process is co-regulated by Fkh1
and Fkh2, which redundantly function in both mitotic progres-
sion and G1 maintenance, acting as both FoxO3a and FoxM1. This
suggests a common role for evolutionary conserved proto-Fox
proteins that regulates orthologous processes, such as cell-cycle
progression and stress response. With this understanding, the
resourcefulness of yeast biology and genetics, in addition to the
ease of environmental control, could be utilized for untangling
the mechanisms of Fox function, especially with regards to cancer
and lifespan.
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